A randomized controlled trial of skin care protocols for facial resurfacing: lessons learned from the Plastic Surgery Educational Foundation's Skin Products Assessment Research study.

Plastic and reconstructive surgery 2011 Vol.127(3) p. 1334-1342

Pannucci CJ, Reavey PL, Kaweski S, Hamill JB, Hume KM, Wilkins EG, Pusic AL

관련 도메인

Abstract

[BACKGROUND] The Skin Products Assessment Research Committee was created by the Plastic Surgery Educational Foundation in 2006. The Skin Products Assessment Research study aims were to (1) develop an infrastructure for Plastic Surgery Educational Foundation-conducted, industry-sponsored research in facial aesthetic surgery and (2) test the research process by comparing outcomes of the Obagi Nu-Derm System versus conventional therapy as treatment adjuncts for facial resurfacing procedures.

[METHODS] The Skin Products Assessment Research study was designed as a multicenter, double-blind, randomized, controlled trial. The study was conducted in women with Fitzpatrick type I to IV skin, moderate to severe facial photodamage, and periocular and/or perioral fine wrinkles. Patients underwent chemical peel or laser facial resurfacing and were randomized to the Obagi Nu-Derm System or a standard care regimen. The study endpoints were time to reepithelialization, erythema, and pigmentation changes.

[RESULTS] Fifty-six women were enrolled and 82 percent were followed beyond reepithelialization. There were no significant differences in mean time to reepithelialization between Obagi Nu-Derm System and control groups. The Obagi Nu-Derm System group had a significantly higher median erythema score on the day of surgery (after 4 weeks of product use) that did not persist after surgery. Test-retest photographic evaluations demonstrated that both interrater and intrarater reliability were adequate for primary study outcomes.

[CONCLUSIONS] The authors demonstrated no significant difference in time to reepithelialization between patients who used the Obagi Nu-Derm System or a standard care regimen as an adjunct to facial resurfacing procedures. The Skin Products Assessment Research team has also provided a discussion of future challenges for Plastic Surgery Educational Foundation-sponsored clinical research for readers of this article.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 skin scispacy 1
해부 peel scispacy 1
합병증 pigmentation 색소침착 dict 1
합병증 facial scispacy 1
합병증 periocular and/or scispacy 1
합병증 perioral fine scispacy 1
합병증 wrinkles scispacy 1
합병증 erythema scispacy 1
약물 [BACKGROUND] The scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 erythema C0041834
Erythema
scispacy 1
질환 Fitzpatrick type I to IV skin scispacy 1
기타 Obagi Nu-Derm scispacy 1
기타 women scispacy 1
기타 Patients scispacy 1

MeSH Terms

Double-Blind Method; Female; Follow-Up Studies; Humans; Middle Aged; Pilot Projects; Rhytidoplasty; Skin Aging; Skin Care; Societies, Medical; Surgery, Plastic; Treatment Outcome; United States

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문